3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL)

NCT07398911 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2026-02-10

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of postmarket bioprosthetic aortic valve in patients with severe aortic regurgitation undergoing transapical transcatheter aortic valve replacement based on 3D simulation technology using a prospective, randomized controlled study.

Conditions

  • Aortic Regurgitation

Interventions

DEVICE

3D simulation technique

using 3D simulation technique

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Chinese Academy of Medical Sciences, Fuwai Hospital

    collaborator OTHER
  • People's Hospital of Xinjiang Uygur Autonomous Region

    collaborator OTHER
  • Henan Provincial Chest Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Fujian Medical University Union Hospital

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • Xinqiao Hospital of Chongqing

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Yan'an Hospital of Kunming City

    collaborator UNKNOWN
  • Dong'e People's Hospital

    collaborator UNKNOWN
  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-30
Primary Completion
2026-05-30
Completion
2026-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07398911 on ClinicalTrials.gov